Application 202423
- Type
- ANDA
- Sponsor
- SUN PHARMA GLOBAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | TABLET; ORAL | 25MG | No | No |
| 002 | SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | TABLET; ORAL | 50MG | No | No |
| 003 | SITAGLIPTIN PHOSPHATE | SITAGLIPTIN PHOSPHATE | TABLET; ORAL | 100MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sitagliptin Phosphate | SITAGLIPTIN PHOSPHATE | Sandoz Inc | cebc8388-c9db-4e27-8d6b-0d9bdc9d766d | 2026-05-10 | Warnings, Adverse reactions | Sitagliptin Phosphate SITAGLIPTIN PHOSPHATE |